神経科学
神経科学臨床研究の技術と科学の向上に尽力する
With an approval rate for neuroscience therapies that is about half that for other drugs, the distinct challenges of clinical research in this area – accelerating recruitment, measuring highly subjective endpoints, countering placebo effects, demonstrating meaningful clinical efficacy – need to be met with an uncommon blend of scientific depth and elegant problem-solving.
ご覧ください
神経科学臨床研究の最新動向に関する弊社の見解をお読みください。
精神疾患やアルツハイマー病などの分野に特化した専門家と専任チームが、比類のない経験とインサイトを生かし、CNC治験に伴う複雑な問題の解決を支援します。
Expertise and resilience, when and where it counts
有意義な成果を達成するために、これほどの精密さと創意工夫が求められる医学研究分野は他にありません。
With over 3,500 highly experienced global industry-leading neuroscience experts, including licensed clinicians, medical monitors, clinical leads, as well as project management and delivery team members, we are committed to helping you overcome the challenges inherent in neuroscience research, offering you:
Scientific and Strategic Therapeutic Excellence
- In-depth, industry-leading clinical and therapeutic expertise in neuroscience for scientifically driven study strategy and protocol design, including rare disease, cell and gene therapy and pediatrics
- Clinical development experts with extensive operational backgrounds who are therapeutically focused on the initial planning of the study and providing continuous steadfast support
Operational Leadership
- フルサービス. Proficiency in project delivery for multi-service and full-service studies through all phases from clinical development through commercialization
- Positive Outcomes. Proven track record for studies and programs, including 56 positive neuroscience studies that enrolled during the COVID-19 pandemic (March 2020 - 2022), for which we provided full service
Clinical Surveillance and Training (CST)
- Dedicated in-house team of endpoint integrity experts including licensed clinical psychologists, neuropsychologists and psychiatrists, with scientific and therapeutic expertise
- Optimization of signal detection for subject protection and the overall study investment for at-risk trials with subjective outcomes
Experienced in a wide range of neuroscience disorders including:
神経科
From recruiting the right patients, to ensuring assessments are completed properly by trained experts and that all stakeholders are aligned, we have managed these complexities and more across a range of challenging neurological study design and difficult-to-recruit indications across neurology including:
• Cerebrovascular
• Neurodegenerative (including Alzheimer’s disease clinical trials )
• Movement
• Neurodevelopmental
• Neuromuscular
• Seizure
• Sleep
精神科
The success of your psychiatry clinical trial hinges on precision in study design, site selection, subject recruitment, the quality and evaluation of raters and the monitoring and delivery of high-quality data. Our experts in psychiatry research offer deep scientific and clinical experience for studies of:
• Mood (including depression, post-partum depression and major depressive disorder clinical trials)
• Anxiety
• Psychosis (including schizophrenia clinical trials)
• Trauma
• Developmental
• Substance abuse
• Psychotherapeutics (including Psychedelics clinical trials)
痛覚脱失
We have an established reputation for our work in pain management, including the design, feasibility, execution, analysis and interpretation of studies in a variety of acute, sub-acute and chronic pain disorders, rare indications and pediatric pain, including:
- Chronic low back pain
- Migraine
- Neuropathic pain
- Osteoarthritis
- Post-surgical pain
眼科
Ophthalmology clinical trials are highly specialized. Our Ophthalmology team consists of more than 360 ophthalmology-trained staff, including eleven board-certified ophthalmologists in North America, Europe and Asia Pacific who are experts in the field and dedicated to vision research with biosimilar, cell & gene therapy and device therapies in areas that include:
- Cornea
- Eyelid
- Glaucoma
- Inherited retinal
- Ocular inflammation
- Optic nerve
- Refractive
- Retina
関連コンテンツ
独自のインサイトをお探しですか？
